INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Capricor Therapeutics, Inc. (CAPR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Core Points - A shareholder class action lawsuit has been filed against Capricor Therapeutics, Inc. alleging that the company made materially false and/or misleading statements regarding its Phase 2 HOPE-2 trial data for deramiocel [1] - The lawsuit specifically concerns the four-year safety and efficacy data from the trial [1] - Shareholders who purchased Capricor shares between October 9, 2024, and July 10, 2025, and suffered significant losses are encouraged to seek legal counsel [2] Legal Information - The deadline for shareholders to request to be appointed as lead plaintiff in the case is September 15, 2025 [3] - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of recovering substantial amounts for shareholders affected by corporate misconduct [3] - The firm has been recognized as an ISS top-rated securities litigation law firm for the years 2021, 2022, and 2023 [3]